Clinical Trial Update: A Study of Synthetic Human Secretin (ChiRhoStim®) Administered Intravenously to Stimulate Exocrine Pancreas Fluid Secretion for Collection Via Endoscope and Laboratory Analysis of DNA Markers [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating ChiRhoStim (synthetic human secretin) given intravenously to stimulate pancreatic exocrine fluid secretion for collection duri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Disease

Drugs mentioned

• CHIRHOSTIM (HUMAN SECRETIN)

Snippet

Sponsor: ChiRhoClin, Inc. | Conditions: Pancreatic Disease | Phase 3 | Status: COMPLETED | Results posted: 2011-12-02